本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ionis Pharmaceuticals, Inc

81.15
+0.55000.68%
盘后81.150.00000.00%19:53 EST
成交量:277.37万
成交额:2.25亿
市值:134.05亿
市盈率:-34.10
高:82.10
开:80.59
低:80.06
收:80.60
52周最高:86.74
52周最低:23.95
股本:1.65亿
流通股本:1.64亿
量比:1.03
换手率:1.69%
股息:- -
股息率:- -
每股收益(TTM):-2.3800
每股收益(LYR):-2.3812
净资产收益率:-70.73%
总资产收益率:-7.32%
市净率:27.41
市盈率(LYR):-34.08

数据加载中...

2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

重要事件披露

Form 8-K - Current report
2026/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities